Theradaptive Gains FDA Approval for Regenerative Spine Therapy
FREDERICK, MARYLAND, April 30, 2026 Theradaptive has received U.S. Food and Drug Administration (FDA) authorization to advance its OASIS...
GCP
Advertisement
Immunome Files FDA NDA for Varegacestat in Tumors
BOTHELL, WASHINGTON, April 29, 2026 Immunome has announced the submission of a New Drug Application (NDA) to the U.S....
Renibus Reports Phase 3 RBT-1 Data at AATS Meeting
SOUTHLAKE, TEXAS, April 30, 2026 Renibus Therapeutics has announced the oral presentation of Phase 3 PROTECT trial data for...
EnGeneIC Doses First Patient in GBM EDV Therapy Trial
SYDNEY, AUSTRALIA, May 01, 2026 EnGeneIC has announced a critical clinical milestone with the first patient dosed in its...
Laguna Gains FDA IND Clearance for LGNA-100 Therapy
SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
Aidoc Secures $150M Led by Goldman Sachs for AI Growth
NEW YORK, April 29, 2026 Aidoc has announced the successful completion of a $150 million Series E funding round...
Paradigm Health, FDA Advance Real-Time Trial Review Model
WASHINGTON & COLUMBUS, OHIO, April 28, 2026 Paradigm Health has announced a landmark research collaboration with the U.S. Food...
Kestrel Therapeutics Doses First Patient in KRAS Trial
WATERTOWN, MASSACHUSETTS, April 28, 2026 Kestrel Therapeutics Inc. has announced a major clinical milestone with the first patient dosed...
Vanda Pharma Publishes Phase III Imsidolimab Data
WASHINGTON, April 28, 2026 Vanda Pharmaceuticals Inc. has announced the publication of pivotal Phase III clinical data evaluating imsidolimab,...
Teva Pharmaceutical Acquires Emalex to Advance Tourette Therapy
PARSIPPANY, NEW JERSEY & CHICAGO, April 29, 2026 Teva Pharmaceutical Industries Ltd. has announced a definitive agreement to acquire...
Advertisement
